Adare Pharmaceuticals

Obesity is a significant global health challenge that requires lifestyle changes and effective pharmacological treatments to overcome. Human glucagon-like peptide 1 (GLP-1) analogs, also called incretin mimetics, have emerged as a promising obesity treatment option. Additionally, oral GLP-1 formulations represent a groundbreaking advance in obesity treatment, offering greater patient comfort and adherence to expand the therapeutic market.

This whitepaper describes the microencapsulation process of coacervation using both aqueous and solvent pathways, and the many benefits for drug developers.

This whitepaper describes the microencapsulation process of coacervation using both aqueous and solvent pathways, and the many benefits for drug developers.

This session of PharmaTalks focuses on the challenges of medication adherence in children and patients with swallowing disorders (dysphasia). On demand presentation Register free

What you will learn: * Dosage form innovations can increase patient adherence. * Parvulet offers a solution for patients with swallowing difficulties.